Model systems for emulating human tissue and physiology in psychiatric research

Area of Science:

• Neuroscience and Stem Cell Biology
• Psychiatric Disorder Modeling

Background:

• Psychiatric disorders like autism spectrum disorder (ASD), schizophrenia (SCZ), and depression present complex modeling challenges.
• Rising mental disorder prevalence necessitates innovative in vitro models for effective treatment development.

Purpose of the Study:

• To compare the efficacy of 2D versus 3D induced pluripotent stem cell (iPSC) models in mimicking neuropsychiatric diseases.
• To assess the potential of 3D organoid models for understanding disease etiology and testing therapeutics.

Main Methods:

• Review and comparative analysis of 2D and 3D iPSC-derived models for neuropsychiatric conditions.
• Evaluation of models for their capacity to replicate neurodevelopment and cellular phenotypes.
• Assessment of 3D organoid models, including brain organoids, for spatial organization, cell diversity, and functional connectivity.

Main Results:

• Traditional 2D cultures are limited in replicating the human brain's intricate architecture and environment.
• 3D organoid models, such as brain organoids, better recapitulate brain tissue's spatial organization, cell diversity, and functional connectivity.
• 3D iPSC technologies offer advanced insights into disease etiology for ASD, SCZ, BD, PTSD, AD, and depression.

Conclusions:

• 3D iPSC models provide a more physiologically relevant context for studying neuropsychiatric diseases than 2D cultures.
• Despite challenges in scalability and maturation, 3D organoids show unparalleled potential for personalized medicine and disease ontogeny elucidation.
• Future directions involve integrating 3D iPSC models with high-throughput technologies and computational approaches for enhanced understanding and treatment.